NIH Halts Hormone Study The National Institutes of Health cancel another hormone-replace therapy study. Due to be completed a year from now, the study was meant to determine the health benefits of estrogen only therapy, but the NIH decided that the risks of stroke outweighed the benefits, such as fewer hip fractures. There were also few other benefits to the therapy, no affect example on heart disease or breast cancer. NPR's Patricia Neighmond reports.
NPR logo

NIH Halts Hormone Study

  • Download
  • <iframe src="https://www.npr.org/player/embed/1741699/1741700" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
NIH Halts Hormone Study

NIH Halts Hormone Study

NIH Halts Hormone Study

  • Download
  • <iframe src="https://www.npr.org/player/embed/1741699/1741700" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

The National Institutes of Health cancel another hormone-replace therapy study. Due to be completed a year from now, the study was meant to determine the health benefits of estrogen only therapy, but the NIH decided that the risks of stroke outweighed the benefits, such as fewer hip fractures. There were also few other benefits to the therapy, no affect example on heart disease or breast cancer. NPR's Patricia Neighmond reports.